Stockreport

Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs, Inc.  (STTK) 
PDF –First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advan [Read more]